citrulline
AssetAlso L-citrulline, NSC-27425
Nitric oxide precursor supporting endothelial function and vasodilation.
- Stage
- Phase 3
- Modality
- Supplement
- Target
- Not known
- 10
- Indications
- 34
- Trials
- 2
- Developers
Indications
10Acute lung injury
Phase 3, Completed, NCT02891837, clinicaltrials.gov, Oct 25, 2026
Atrioventricular septal defect
Phase 3, Terminated, NCT05253209, clinicaltrials.gov, Oct 25, 2026
Congenital heart disease
Phase 3, Completed, NCT00335244, clinicaltrials.gov, Oct 30, 2026
7 more
In the full profile
- Targets and what it contains1
- Owner and partners2
- Trials34
- Evidence for its targets2
- Signals15
Every asset’s record: target, stage, trials and the evidence behind it.